Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 6-chloro-2-fluoro-3-hydroxy- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

91659-28-8

Post Buying Request

91659-28-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91659-28-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 91659-28-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,6,5 and 9 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 91659-28:
(7*9)+(6*1)+(5*6)+(4*5)+(3*9)+(2*2)+(1*8)=158
158 % 10 = 8
So 91659-28-8 is a valid CAS Registry Number.

91659-28-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-Chloro-2-fluoro-3-hydroxybenzoic acid

1.2 Other means of identification

Product number -
Other names 6-chloro-2-fluoro-3-hydroxy-benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:91659-28-8 SDS

91659-28-8Relevant academic research and scientific papers

1H-PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS FOR INHIBITING RAF KINASE

-

Page/Page column 44; 45, (2011/04/14)

Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. [FORMULA I]

BENZAMIDE DERIVATIVES AS EP4 RECEPTOR AGONISTS

-

Page/Page column 59, (2008/12/06)

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, R4, R5, m, n and X are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

PYRIMIDINE COMPOUNDS AND METHODS OF USE

-

Page/Page column 110-111, (2010/11/24)

The invention provides pyrimidine compounds having formula (A): The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, and various other specific receptor and non-receptor kinases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 91659-28-8